Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 24;14(10):e0223887.
doi: 10.1371/journal.pone.0223887. eCollection 2019.

A review of a 13-month period of FilmArray Meningitis/Encephalitis panel implementation as a first-line diagnosis tool at a university hospital

Affiliations

A review of a 13-month period of FilmArray Meningitis/Encephalitis panel implementation as a first-line diagnosis tool at a university hospital

Agathe Boudet et al. PLoS One. .

Abstract

Early diagnosis and treatment of meningitis and encephalitis is essential for reducing both their morbidity and mortality. The FilmArray® Meningitis/Encephalitis (FA-M/E) panel is a recently available molecular tool allowing the simultaneous detection of 14 pathogens in about one hour. We evaluated its routine use over a 13-month period at Nîmes University Hospital, France. Cerebrospinal fluid (CSF) specimens were prospectively analyzed, independently of cell count; results were retrospectively analyzed and positive results compared to clinical and microbiological data. Among the 708 patients included (734 CSF samples), 89 (12.6%) had a positive FA-M/E panel, 71 (80%) for a viral pathogen and 18 (20%) for a bacterial pathogen. Enterovirus and HHV-6 were the main detected pathogens. Mean time-to-results was 1h46mn. Four non-clinically relevant results were detected (3 HHV-6 and 1 Haemophilus influenzae) on the basis of inconsistent clinical and/or biological data, and/or after visualization of melting curves. No CSF pleocytosis was observed in 11% of the patients with a positive FA-M/E panel. For the 18 patients with a positive FA-M/E panel for a bacterial pathogen, five (28%) had CSF samples showing a positive Gram stain allowing an early diagnosis of bacterial infection and 67% had CSF displaying a positive culture. Altogether the panel detected 5 cases of bacterial M/E (29%) not diagnosed by culture. Despite undeniable advantages, mainly ease of use, quick result availability, and an extremely low rate of invalid results, measures should be implemented to limit false-positive results due to contamination and a careful interpretation based on the overall data for each patient is required.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Algorithm for performing the FilmArray Meningitis/Encephalitis assay on CSF samples.
All children in the study were put into the “pediatric & neonatology” category.
Fig 2
Fig 2. Chronogram presenting the weekly results of the FilmArray Meningitis/Encephalitis panel during the study period.
Grey: no pathogen detected. Each colored square represents a patient with positive detection (for the few patients with successive positive detections, only the first positive detection has been considered in the figure). The pathogens detected are indicated by a specific color. A bicolor square indicates the unique co-detection of two pathogens during the study. N. meningitidis serogroup (B or C) is indicated in the corresponding area.
Fig 3
Fig 3. Melting curves for HHV-6 detection declared positive by the system.
A & B. Noisy melting curves observed for two analyses of CSF with non-confirmed detection of HHV-6 by an alternative method. The two analyses showed that 2 replicates out of the 3 performed by the system were positive. C. Melting curves observed after analysis of a CSF sample with confirmed detection of HHV-6 by an alternative method. The 3 replicates performed by the system are positive.

References

    1. Dodge PR, Swartz MN. Bacterial meningitis—a review of selected aspects. II. Special neurologic problems, postmeningitic complications and clinicopathological correlations. N Engl J Med. 1965;272:954–960. 10.1056/NEJM196505062721806 - DOI - PubMed
    1. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354:44–53. 10.1056/NEJMra052116 - DOI - PubMed
    1. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129:862–869. 10.7326/0003-4819-129-11_part_1-199812010-00004 - DOI - PubMed
    1. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23:467–492. 10.1128/CMR.00070-09 - DOI - PMC - PubMed
    1. Martin NG, Iro MA, Sadarangani M, Goldacre R, Pollard AJ,Goldacre MJ. Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study. Lancet Infect Dis. 2016;16:1279–1287. 10.1016/S1473-3099(16)30201-8 - DOI - PubMed

MeSH terms